Wei Zheng

7.0k total citations
212 papers, 4.5k citations indexed

About

Wei Zheng is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Wei Zheng has authored 212 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Psychiatry and Mental health, 72 papers in Pharmacology and 44 papers in Biological Psychiatry. Recurrent topics in Wei Zheng's work include Treatment of Major Depression (68 papers), Tryptophan and brain disorders (44 papers) and Schizophrenia research and treatment (43 papers). Wei Zheng is often cited by papers focused on Treatment of Major Depression (68 papers), Tryptophan and brain disorders (44 papers) and Schizophrenia research and treatment (43 papers). Wei Zheng collaborates with scholars based in China, Macao and Australia. Wei Zheng's co-authors include Yu‐Tao Xiang, Gábor S. Ungvári, Chee H. Ng, Yuping Ning, Dong-Bin Cai, Yanling Zhou, Yanni Zhan, Lijian Chen, Xiaofeng Lan and Xin-Hu Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Wei Zheng

200 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Zheng China 36 1.5k 1.3k 1.1k 656 653 212 4.5k
S. Danielle Canada 33 1.2k 0.8× 1.5k 1.2× 1.1k 1.0× 838 1.3× 682 1.0× 80 3.9k
Yuping Ning China 38 1.4k 0.9× 1.3k 1.0× 1.4k 1.2× 891 1.4× 1.4k 2.1× 344 5.5k
Mehala Subramaniapillai Canada 34 948 0.6× 1.0k 0.8× 1.1k 1.0× 855 1.3× 455 0.7× 117 4.7k
Joanna K. Soczynska Canada 43 2.8k 1.9× 985 0.8× 1.6k 1.4× 662 1.0× 599 0.9× 82 5.8k
Katherine J. Aitchison United Kingdom 44 1.9k 1.3× 1.1k 0.9× 1.7k 1.5× 816 1.2× 716 1.1× 159 6.0k
Nozomi Takeshima Japan 16 839 0.6× 1.3k 1.1× 735 0.6× 855 1.3× 501 0.8× 29 3.6k
Yu Hayasaka Japan 15 832 0.6× 1.3k 1.1× 734 0.6× 851 1.3× 498 0.8× 25 3.5k
Taro Kishi Japan 42 1.9k 1.3× 990 0.8× 834 0.7× 510 0.8× 781 1.2× 233 5.5k
Chi‐Un Pae South Korea 42 2.4k 1.6× 1.8k 1.4× 1.4k 1.2× 650 1.0× 564 0.9× 310 6.9k
Keming Gao United States 39 2.3k 1.6× 703 0.6× 600 0.5× 493 0.8× 930 1.4× 138 4.8k

Countries citing papers authored by Wei Zheng

Since Specialization
Citations

This map shows the geographic impact of Wei Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zheng more than expected).

Fields of papers citing papers by Wei Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zheng. The network helps show where Wei Zheng may publish in the future.

Co-authorship network of co-authors of Wei Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zheng. A scholar is included among the top collaborators of Wei Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zheng. Wei Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xingbing, Rui‐Hua Xu, Dewei Shang, et al.. (2025). Kynurenine pathway metabolites predict antianhedonic effects of electroconvulsive therapy in patients with treatment-resistant depression. Journal of Affective Disorders. 379. 764–771.
2.
Su, Zhen, et al.. (2024). Magnetic seizure therapy versus electroconvulsive therapy for major mental disorders: A systematic review. Asian Journal of Psychiatry. 103. 104336–104336.
3.
Zheng, Wei, et al.. (2023). Transcranial alternating current stimulation for chronic insomnia: A systematic review. Asian Journal of Psychiatry. 82. 103477–103477. 5 indexed citations
4.
Cai, Dong-Bin, et al.. (2023). Adjunctive continuous theta burst stimulation for major depressive disorder or bipolar depression: A meta-analysis of randomized controlled studies. Journal of Affective Disorders. 346. 266–272. 8 indexed citations
5.
Zheng, Wei, Dong-Bin Cai, Jianhua Chen, et al.. (2023). Adjunctive transcranial alternating current stimulation for patients with major depressive disorder: A systematic review and meta-analysis. Frontiers in Psychiatry. 14. 1154354–1154354. 11 indexed citations
6.
Zhang, Shufei, Shenglin She, Zezhi Li, et al.. (2023). Multi-modal MRI measures reveal sensory abnormalities in major depressive disorder patients: A surface-based study. NeuroImage Clinical. 39. 103468–103468. 7 indexed citations
7.
Zheng, Wei, Xin-Hu Yang, Yanling Zhou, et al.. (2022). Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions. International Journal of Psychiatry in Clinical Practice. 27(2). 145–150. 2 indexed citations
8.
Zheng, Wei, Yanling Zhou, Chengyu Wang, et al.. (2021). Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression. Journal of Affective Disorders. 300. 109–113. 24 indexed citations
9.
Zhou, Yanling, Fengchun Wu, Chengyu Wang, et al.. (2020). Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder. Journal of Affective Disorders. 276. 608–615. 23 indexed citations
10.
Zheng, Wei, Dong-Bin Cai, Wei Zheng, et al.. (2020). Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies. Journal of Affective Disorders. 265. 63–70. 73 indexed citations
11.
Zheng, Wei, Wen Li, Han Qi, et al.. (2020). Adjunctive folate for major mental disorders: A systematic review. Journal of Affective Disorders. 267. 123–130. 26 indexed citations
12.
Zheng, Wei, Qing-E Zhang, Dong-Bin Cai, et al.. (2019). Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials. Schizophrenia Research. 209. 12–21. 28 indexed citations
13.
Yi, Lei, et al.. (2019). Effectiveness comparisons of acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Medicine. 98(17). e15199–e15199. 1 indexed citations
14.
Zhou, Yanling, Wei Zheng, Weijian Liu, et al.. (2018). Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Journal of Psychopharmacology. 32(10). 1118–1126. 55 indexed citations
15.
Zhu, Xiaomin, Wei Zheng, Xiaohong Li, et al.. (2018). Electroconvulsive therapy for older adult patients with major depressive disorder: a systematic review of randomized controlled trials. Psychogeriatrics. 18(6). 468–475. 26 indexed citations
16.
Zheng, Wei, Yanling Zhou, Weijian Liu, et al.. (2018). Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. Journal of Affective Disorders. 246. 241–247. 51 indexed citations
17.
Li, Haiyan, Xiaoyin Ke, Qing Dai, et al.. (2017). Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population. PLoS ONE. 12(10). e0186143–e0186143. 72 indexed citations
18.
Chen, Rui, Wei Zheng, Shi-Bin Wang, et al.. (2017). Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials. Journal of International Medical Research. 46(1). 22–32. 14 indexed citations
19.
Zheng, Wei, Tong Guo, Gábor S. Ungvári, et al.. (2017). Memory Impairment Following Electroconvulsive Therapy in Chinese Patients with Schizophrenia: Meta-Analysis of Randomized Controlled Trials. Perspectives In Psychiatric Care. 54(2). 107–114. 15 indexed citations
20.
Zheng, Wei, Yu‐Tao Xiang, Yu‐Tao Xiang, et al.. (2016). Efficacy and safety of adjunctive topiramate for schizophrenia: a meta‐analysis of randomized controlled trials. Acta Psychiatrica Scandinavica. 134(5). 385–398. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Danielle Breakdown of academic impact, for papers by Yuping Ning Breakdown of academic impact, for papers by Mehala Subramaniapillai Breakdown of academic impact, for papers by Joanna K. Soczynska Breakdown of academic impact, for papers by Katherine J. Aitchison Breakdown of academic impact, for papers by Nozomi Takeshima Breakdown of academic impact, for papers by Yu Hayasaka Breakdown of academic impact, for papers by Taro Kishi Breakdown of academic impact, for papers by Chi‐Un Pae Breakdown of academic impact, for papers by Keming Gao
Rankless by CCL
2026